Detalhe da pesquisa
1.
Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data.
Clin Gastroenterol Hepatol
; 2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110061
2.
Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.
Br J Clin Pharmacol
; 87(2): 471-482, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484575
3.
A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
Eur J Haematol
; 103(2): 137-139, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102471
4.
[Peranesthesic Anaphylactic Shocks: Contribution of a Clinical Data Warehouse]. / Chocs anaphylactiques peranesthésiques : contribution d'un entrepôt de données cliniques.
Therapie
; 2015 Oct 16.
Artigo
em Francês
| MEDLINE | ID: mdl-26475750
5.
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Eur J Cancer
; 179: 28-47, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473326
6.
Complicated atazanavir-associated cholelithiasis: a report of 14 cases.
Clin Infect Dis
; 55(9): 1270-2, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22820540
7.
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.
Therapie
; 75(5): 471-480, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732241
8.
Dress syndrome secondary to different combinations of targeted therapy (iBRAF + iMEK).
Eur J Dermatol
; 30(3): 303-304, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666930
9.
Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer.
Eur J Cancer
; 115: 107-110, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132740